ATE279942T1 - Mehrwertige impstoffzusammensetzung mit gemischten trägern - Google Patents

Mehrwertige impstoffzusammensetzung mit gemischten trägern

Info

Publication number
ATE279942T1
ATE279942T1 AT98925715T AT98925715T ATE279942T1 AT E279942 T1 ATE279942 T1 AT E279942T1 AT 98925715 T AT98925715 T AT 98925715T AT 98925715 T AT98925715 T AT 98925715T AT E279942 T1 ATE279942 T1 AT E279942T1
Authority
AT
Austria
Prior art keywords
added value
vaccine composition
mixed carriers
polyosides
conjugates
Prior art date
Application number
AT98925715T
Other languages
English (en)
Inventor
Odile Leroy
Original Assignee
Aventis Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9507086&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE279942(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pasteur filed Critical Aventis Pasteur
Application granted granted Critical
Publication of ATE279942T1 publication Critical patent/ATE279942T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT98925715T 1997-05-14 1998-05-14 Mehrwertige impstoffzusammensetzung mit gemischten trägern ATE279942T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9706210A FR2763244B1 (fr) 1997-05-14 1997-05-14 Composition vaccinale multivalente a porteur mixte
PCT/FR1998/000966 WO1998051339A1 (fr) 1997-05-14 1998-05-14 Composition vaccinale multivalente a porteur mixte

Publications (1)

Publication Number Publication Date
ATE279942T1 true ATE279942T1 (de) 2004-11-15

Family

ID=9507086

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98925715T ATE279942T1 (de) 1997-05-14 1998-05-14 Mehrwertige impstoffzusammensetzung mit gemischten trägern

Country Status (20)

Country Link
US (2) US7862823B1 (de)
EP (1) EP0983087B1 (de)
JP (1) JP2001525815A (de)
KR (1) KR100709628B1 (de)
CN (1) CN1154509C (de)
AT (1) ATE279942T1 (de)
AU (1) AU748716B2 (de)
BR (1) BR9808772A (de)
CA (1) CA2289009C (de)
CZ (1) CZ295272B6 (de)
DE (1) DE69827127T2 (de)
ES (1) ES2227840T3 (de)
FR (1) FR2763244B1 (de)
HU (1) HUP0002322A3 (de)
IL (3) IL132669A0 (de)
NO (1) NO320415B1 (de)
NZ (1) NZ500738A (de)
PL (1) PL189653B1 (de)
PT (1) PT983087E (de)
WO (1) WO1998051339A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034792A1 (de) * 1999-03-11 2000-09-13 Pasteur Merieux Serums Et Vaccins Intranasale Verabreichung von Pneumokokken-Polysaccharid Impfstoffen
JP4846906B2 (ja) * 1999-03-19 2011-12-28 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
GB9909077D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Biolog Novel compositions
FR2806304B1 (fr) * 2000-03-17 2002-05-10 Aventis Pasteur Conjugues polysaccharidiques du pneumocoque a usage vaccinal contre le tetanos et la diphterie
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
GB0130215D0 (en) * 2001-12-18 2002-02-06 Glaxosmithkline Biolog Sa Vaccine
FR2850106B1 (fr) * 2003-01-17 2005-02-25 Aventis Pasteur Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5
GB0409745D0 (en) 2004-04-30 2004-06-09 Chiron Srl Compositions including unconjugated carrier proteins
GB0500787D0 (en) 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
EP2272531A3 (de) 2004-04-30 2011-04-13 Novartis Vaccines and Diagnostics S.r.l. Integration von Meningokokkenkonjugatimpfstoff
GB0419846D0 (en) * 2004-09-07 2004-10-13 Chiron Srl Vaccine adjuvants for saccharides
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
CN102716480B (zh) 2005-04-08 2023-03-21 惠氏有限责任公司 多价肺炎球菌多糖-蛋白质缀合物组合物
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US9931397B2 (en) 2005-06-27 2018-04-03 Glaxosmithkline Biologicals S.A. Immunogenic composition
JP5135220B2 (ja) 2005-09-01 2013-02-06 ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー 血清群ｃ髄膜炎菌を含む複数ワクチン接種
CN101378778B (zh) 2005-12-22 2013-02-06 葛兰素史密丝克莱恩生物有限公司 肺炎球菌多糖缀合物疫苗
TW200806315A (en) * 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
US8808707B1 (en) 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
US20100074918A1 (en) 2007-05-02 2010-03-25 Jan Poolman Vaccine
EP2170391B1 (de) * 2007-06-20 2017-01-18 Pfizer Ireland Pharmaceuticals Modifizierte polysaccharide für konjugat-impfstoffe
AU2008267208B2 (en) 2007-06-26 2012-01-19 Glaxosmithkline Biologicals S.A. Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
US20130071422A1 (en) 2010-03-18 2013-03-21 Michele Pallaoro Adjuvanted vaccines for serogroup b meningococcus
BR112013005049A2 (pt) 2010-09-02 2016-05-31 Sanofi Pasteur estabilizador para a preparação de uma composição vacina da pólio seca injetável
GB201101665D0 (en) 2011-01-31 2011-03-16 Novartis Ag Immunogenic compositions
MX354103B (es) * 2012-01-30 2018-02-13 Serum Inst India Ltd Composicion inmunogenica.
CA2896552A1 (en) 2012-10-03 2014-04-10 Novartis Ag Immunogenic compositions
AR101256A1 (es) 2014-07-21 2016-12-07 Sanofi Pasteur Composición vacunal que comprende ipv y ciclodextrinas
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
CN105695497B (zh) 2014-11-27 2019-09-24 中国人民解放军军事医学科学院生物工程研究所 一种细菌多糖修饰的重组融合蛋白的制备方法及其应用
CN107810010A (zh) 2015-06-23 2018-03-16 生物E有限公司 多价肺炎球菌结合疫苗
TWI789357B (zh) * 2016-08-05 2023-01-11 南韓商Ｓｋ生物科技股份有限公司 多價肺炎球菌多醣-蛋白質共軛物組成物(二)
IL264553B2 (en) * 2016-08-05 2023-04-01 Sanofi Pasteur Inc A multivalent pneumococcal protein-polysaccharide conjugate preparation
UA126385C2 (uk) 2016-09-30 2022-09-28 Байолоджикал І Лімітед Композиції полівалентної пневмококової вакцини, що містять кон'югати полісахарид-білок
CA3048981A1 (en) 2016-12-30 2018-07-05 Sutrovax, Inc. Polypeptide-antigen conjugates with non-natural amino acids
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
KR102634811B1 (ko) 2017-06-10 2024-02-06 인벤트프라이즈 인크. 면역원성과 항원항체 결합성이 개선된 2가 또는 다가 접합체 다당류를 가진 다가 접합체 백신
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
US11123417B2 (en) * 2018-02-05 2021-09-21 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
CA3087572A1 (en) 2018-02-05 2019-08-08 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
AU2019256218A1 (en) 2018-04-18 2020-12-03 Sk Bioscience Co., Ltd. Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof
CN112543649A (zh) 2018-07-04 2021-03-23 Vaxcyte公司 免疫原性缀合物的改进
WO2020010016A1 (en) 2018-07-04 2020-01-09 Sutrovax, Inc. Self-adjuvanted immunogenic conjugates
WO2023200704A1 (en) 2022-04-11 2023-10-19 Sanofi Pasteur Inc. Protein-saccharide conjugation with sodium cyanoborohydride

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5639022A (en) * 1979-09-05 1981-04-14 Hayashibara Biochem Lab Inc Preparation of vaccine
NZ220932A (en) * 1986-07-03 1990-05-28 Victoria State Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
JP4846906B2 (ja) 1999-03-19 2011-12-28 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
GB0130215D0 (en) 2001-12-18 2002-02-06 Glaxosmithkline Biolog Sa Vaccine

Also Published As

Publication number Publication date
NZ500738A (en) 2002-03-28
DE69827127D1 (de) 2004-11-25
US20110117123A1 (en) 2011-05-19
US8029798B2 (en) 2011-10-04
CZ295272B6 (cs) 2005-06-15
NO995349L (no) 1999-11-02
PL189653B1 (pl) 2005-09-30
AU7773098A (en) 1998-12-08
IL132669A (en) 2010-11-30
BR9808772A (pt) 2000-09-05
FR2763244B1 (fr) 2003-08-01
NO995349D0 (no) 1999-11-02
CN1154509C (zh) 2004-06-23
CA2289009A1 (fr) 1998-11-19
WO1998051339A1 (fr) 1998-11-19
KR100709628B1 (ko) 2007-04-19
EP0983087B1 (de) 2004-10-20
FR2763244A1 (fr) 1998-11-20
CN1255861A (zh) 2000-06-07
DE69827127T2 (de) 2005-03-24
HUP0002322A2 (hu) 2000-11-28
US7862823B1 (en) 2011-01-04
NO320415B1 (no) 2005-12-05
ES2227840T3 (es) 2005-04-01
PT983087E (pt) 2005-01-31
PL336704A1 (en) 2000-07-03
IL132669A0 (en) 2001-03-19
EP0983087A1 (de) 2000-03-08
CZ9904021A3 (en) 2001-06-13
CA2289009C (fr) 2011-04-26
KR20010012477A (ko) 2001-02-15
AU748716B2 (en) 2002-06-13
HUP0002322A3 (en) 2001-12-28
IL183296A0 (en) 2007-09-20
JP2001525815A (ja) 2001-12-11

Similar Documents

Publication Publication Date Title
ATE279942T1 (de) Mehrwertige impstoffzusammensetzung mit gemischten trägern
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
DE69421639T2 (de) Aza-Zyklohexapeptide
DK1200418T3 (da) Nematodicide trifluorbutener
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
SE9802937D0 (sv) Novel compounds
NO995858D0 (no) Ny klasse kationiske nukleinsyre-overföringsmidler
ID25478A (id) Agonis 5-ht1f
PT1011329E (pt) Paclitaxeis de 7-metiltio-oxometilo e 7-metiltiodioxometilo
EP1059089A4 (de) Mittel zur prävention/behandlung entzündlicher darmerkrankungen
DK0598719T3 (da) Receptorkonjugater til destinering af lægemidler og andre midler
BR9812002A (pt) Compostos com efeito antiprimeiro-passe

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0983087

Country of ref document: EP

RZN Patent revoked